The Law Firm Of Levi & Korsinsky, LLP Announces Investigation Into Possible Breaches Of Fiduciary Duty By The Board Of Synovis Life Technologies Inc. In Connection With The Sale Of The Company To Baxter International Inc.
Levi & Korsinsky is investigating the Board of Directors of Synovis Life
Levi & Korsinsky is investigating the Board of Directors of Synovis Life Technologies, Inc. (“Synovis” or the “Company”) (NASDAQ: SYNO) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Baxter International Inc. (NYSE: BAX). Under the terms of the transaction, Synovis shareholders will receive $28 per share of Synovis stock they own. The transaction has a total approximate value of $325 million. Click here to learn how to join the action: http://www.zlk.com/synovis-life-technologies-syno, or call: 877-363-5972. The investigation concerns whether the Synovis Board of Directors breached their fiduciary duties to Synovis stockholders by failing to adequately shop the Company before entering into this transaction and whether Baxter International Inc. is underpaying for Synovis shares, thus unlawfully harming Synovis stockholders. If you own common stock in Synovis and wish to obtain additional information, please contact Joseph E. Levi, Esq. either via email at firstname.lastname@example.org or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or http://www.zlk.com. Levi & Korsinsky has extensive expertise in prosecuting investor securities litigation involving financial fraud and represents investors throughout the nation, concentrating its practice in securities and shareholder litigation. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.
Synovis Life Technologies (Nasdaq:SYNO) hit a new 52-week high Tuesday as it is currently trading at $28.01, above its previous 52-week high of $28 with 31,366 shares traded as of 1:32 p.m. ET. Average volume has been 165,800 shares over the past 30 days.
Synovis Life Technologies (Nasdaq:SYNO) hit a new 52-week high Tuesday as it is currently trading at $27.98, above its previous 52-week high of $27.97 with 52,394 shares traded as of 3 p.m. ET. Average volume has been 165,800 shares over the past 30 days.
Shares of Synovis Life Technologies (Nasdaq:SYNO) were gapping up Tuesday morning with an open price 50.5% higher than Monday's closing price. The stock closed at $18.44 yesterday and opened today's trading at $27.75.